Determination of Platelet Count and Platelet Indices among Sudanese Patients with Chronic Kidney Disease

ORIGINAL ARTICLE
Azza Abdelrahim, Husham O. Elzein

 
For citation: Abdelrahim A, Elzein HO. Determination of Platelet Count and Platelet Indices among Sudanese Patients with Chronic Kidney Disease. International Journal of Biomedicine. 2024;14(1):41-44. doi:10.21103/Article14(1)_OA5
 
Originally published March 1, 2024

Keywords: 
chronic kidney disease • platelet count • platelet indices
References: 
  1. Summary of Recommendation Statements. Kidney Int Suppl (2011). 2013 Jan;3(1):5-14. doi: 10.1038/kisup.2012.77. PMID: 25598998; PMCID: PMC4284512.
  2. Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA). The systemic nature of CKD. Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi: 10.1038/nrneph.2017.52. Epub 2017 Apr 24. PMID: 28435157.
  3. Mandelbrot DA, Reese PP, Garg N, Thomas CP, Rodrigue JR, Schinstock C, Doshi M, Cooper M, Friedewald J, Naik AS, Kaul DR, Ison MG, Rocco MV, Verbesey J, Hladunewich MA, Ibrahim HN, Poggio ED. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Am J Kidney Dis. 2020 Mar;75(3):299-316. doi: 10.1053/j.ajkd.2019.10.005. Epub 2020 Jan 29. PMID: 32007233.
  4. Gaitonde DY, Cook DL, Rivera IM. Chronic Kidney Disease: Detection and Evaluation. Am Fam Physician. 2017 Dec 15;96(12):776-783. PMID: 29431364.
  5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266. PMID: 11904577.
  6. McCarley P. The KDOQI clinical practice guidelines and clinical practice recommendations for treating anemia in patients with chronic kidney disease: implications for nurses. Nephrol Nurs J. 2006 Jul-Aug;33(4):423-6, 445; quiz 427-8. PMID: 17002000.
  7. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 Jun;67(6):2089-100. doi: 10.1111/j.1523-1755.2005.00365.x. PMID: 15882252.
  8. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S4-16. doi: 10.1053/j.ajkd.2008.07.048. PMID: 19231760.
  9. Lu MC, Chen IJ, Hsu LT, Chen YJ, Tsou MT, Tung TH, Chen JY. Metabolic Risk Factors Associated With Chronic Kidney Disease in a Middle-Aged and Elderly Taiwanese Population: A Cross-Sectional Study. Front Med (Lausanne). 2021 Nov 16;8:748037. doi: 10.3389/fmed.2021.748037. PMID: 34869437; PMCID: PMC8635038.
  10. Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. PMID: 27383068; PMCID: PMC4934905.
  11. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018 Jun 1;96(6):414-422D. doi: 10.2471/BLT.17.206441. Epub 2018 Apr 20. PMID: 29904224; PMCID: PMC5996218.
  12. Zhang W, Shi W, Liu Z, Gu Y, Chen Q, Yuan W, Zhang Y, Gong L, Zhou R, Li M, Cheng H, Liu J, Cen J, Huang C, Ren Y, Mao P, Xing C, Hong F, Jiang D, Wang L, Xu G, Liu J, Chen N. A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease. Sci Rep. 2016 Dec 20;6:38768. doi: 10.1038/srep38768. PMID: 27995959; PMCID: PMC5171924.
  13. Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ. 2013 Jun 11;185(9):E417-23. doi: 10.1503/cmaj.120833. Epub 2013 May 6. PMID: 23649413; PMCID: PMC3680588.
  14. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis. 2010 Apr;55(4):660-70. doi: 10.1053/j.ajkd.2009.12.011. PMID: 20138414.
  15. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012 Jan 14;379(9811):165-80. doi: 10.1016/S0140-6736(11)60178-5. Epub 2011 Aug 15. PMID: 21840587.
  16. Girndt M, Trocchi P, Scheidt-Nave C, Markau S, Stang A. The Prevalence of Renal Failure. Results from the German Health Interview and Examination Survey for Adults, 2008-2011 (DEGS1). Dtsch Arztebl Int. 2016 Feb 12;113(6):85-91. doi: 10.3238/arztebl.2016.0085. PMID: 26931624; PMCID: PMC4782264.
  17. Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ; European CKD Burden Consortium. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2016 Jul;27(7):2135-47. doi: 10.1681/ASN.2015050542. Epub 2015 Dec 23. PMID: 26701975; PMCID: PMC4926978.
  18. Fraser SD, Aitken G, Taal MW, Mindell JS, Moon G, Day J, O'Donoghue D, Roderick PJ. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLoS One. 2015 Feb 20;10(2):e0118676. doi: 10.1371/journal.pone.0118676. PMID: 25700182; PMCID: PMC4336286.
  19. Abd ElHafeez S, Bolignano D, D'Arrigo G, Dounousi E, Tripepi G, Zoccali C. Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review. BMJ Open. 2018 Jan 10;8(1):e015069. doi: 10.1136/bmjopen-2016-015069. PMID: 29326180; PMCID: PMC5780690.
  20. Abu-Aisha H, Elhassan A, Khamis A, Abu-Elmaali A. Chronic kidney disease in police forces households in Khartoum, Sudan: pilot report. Arab Journal of Nephrology and Transplantation. 2009;2(2):21-6.
  21. Machlus KR, Italiano JE Jr. The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol. 2013 Jun 10;201(6):785-96. doi: 10.1083/jcb.201304054. PMID: 23751492; PMCID: PMC3678154.
  22. van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019 Mar;16(3):166-179. doi: 10.1038/s41569-018-0110-0. PMID: 30429532.
  23. Christiansen CF, Schmidt M, Lamberg AL, Horváth-Puhó E, Baron JA, Jespersen B, Sørensen HT. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014 Sep;12(9):1449-54. doi: 10.1111/jth.12652. Epub 2014 Jul 29. PMID: 25040558.
  24. Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, Tonelli M; Alberta Kidney Disease Network. Cause of Death in Patients with Reduced Kidney Function. J Am Soc Nephrol. 2015 Oct;26(10):2504-11. doi: 10.1681/ASN.2014070714. Epub 2015 Mar 2. PMID: 25733525; PMCID: PMC4587695.
  25. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004 Oct;30(5):579-89. doi: 10.1055/s-2004-835678. PMID: 15497100.
  26. Ocak G, Rookmaaker MB, Algra A, de Borst GJ, Doevendans PA, Kappelle LJ, Verhaar MC, Visseren FL; SMART Study Group. Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study. J Thromb Haemost. 2018 Jan;16(1):65-73. doi: 10.1111/jth.13904. Epub 2017 Dec 20. PMID: 29125709.
  27. Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H. Platelet Function in CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol. 2021 Jul;32(7):1583-1598. doi: 10.1681/ASN.2020101440. Epub 2021 May 3. PMID: 33941607; PMCID: PMC8425648.
  28. Arogundade FA, Bappa A, Sanusi AA, Akinola NO, Adediran IA, Akinsola A. Haematologic Indices and the Response to Erythropoetin Therapy in Chronic Renal Failure. Tropical Journal of Nephrology. 2006;1(1):13-20.
  29. Mohamed Ali MS, Babiker MA, Merghani LB, Ali FA, Abdulmajeed MH. Hematological changes post-hemo and peritoneal dialysis among renal failure patients in Sudan. Saudi J Kidney Dis Transpl. 2008 Mar;19(2):274-9. PMID: 18310883.
  30. Shittu AO, Chijioke A, Biliaminu S, Makusidi A, Sanni M, Abdul-Rahman M, Abdul-Azeez I. Haematological profile of patients with chronic kidney disease in Nigeria. Journal of Nephrology and Renal transplantation. 2013;5(1):2-10.
  31. Bilen Y, Cankaya E, Keles M, Gulcan E, Uyanik A, Turkeli M, Albayrak B, Yildirim R. Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients? Ren Fail. 2014 Feb;36(1):69-72. doi: 10.3109/0886022X.2013.832310. Epub 2013 Sep 13. PMID: 24028675.
  32. Schoorl M, Grooteman MP, Bartels PC, Nubé MJ. Aspects of platelet disturbances in haemodialysis patients. Clin Kidney J. 2013 Jun;6(3):266-271. doi: 10.1093/ckj/sft033. Epub 2013 Mar 29. PMID: 24596657; PMCID: PMC3941307

Download Article
Received December 11, 2023.
Accepted January 20, 2024.
©2024 International Medical Research and Development Corporation.